Evidence map›Paper›PMID 42331889›Full record

ArticleScientific reports2026

PD-YOLO: a high-precision detection network for fine-grained lung cancer and multi-scale pulmonary nodules in CT images.

Conghan Yang, Chen Zhang, Kuisong Wang, Baiyang Wu, Ziwei Li

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Conghan Yang *Department of Intensive care unit, Jinjiang Municipal Hospital, Jinjiang, 362200, Fujian, China. youngmuxin@126.com.
Chen Zhang *Department of General Surgery, the Second Affiliated Hospital of Fujian Medical University, QuanZhou, 362000, Fujian, China.
Kuisong Wang *Department of General Practice, Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Baiyang WuQuanzhou Hospital of Traditional Chinese medicine, Quanzhou, China.
Ziwei LiDepartment of Anesthesiology, Affiliated Hospital of Medical School, Jinling Hospital, Nanjing University, Nanjing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Timely and accurate Computed Tomography (CT) screening is crucial for the early clinical treatment of lung cancer and preventing the progression of malignant pulmonary nodules. However, owing to the large scale variations and blurred boundaries of lesions, existing deep learning models struggle to strike an optimal balance between computational costs, receptive field size, and the precise reconstruction of fine details. To address these challenges, this paper integrates three complementary components-A2C2f_DFFN, SPPF_LSKA, and DySample-into the YOLOv12n framework to construct PD-YOLO, a high-precision fine-grained lung cancer detection model. The main contribution lies in the synergistic optimization of these modules for CT‑based pulmonary lesion detection, rather than the theoretical novelty of any single component. Specifically, we introduce the A2C2f_DFFN module, which utilizes a Dynamic Feed-Forward Network to significantly enhance the non-linear feature representation of low-contrast early lesions. Furthermore, the SPPF_LSKA module is designed by combining Spatial Pyramid Pooling with Large Separable Kernel Attention, which expands the effective receptive field with extremely low computational overhead to handle large-scale massive tumor consolidations typical of advanced lung cancer. Additionally, an ultra-lightweight dynamic upsampling module (DySample) is employed to adaptively reconstruct high-resolution features, effectively mitigating the loss of edge textures and minor infiltrates during feature propagation. Extensive experiments on a chest CT dataset containing 4200 images demonstrate that PD-YOLO achieves a mean Average Precision (mAP @0.5) of 97.3%, outperforming state-of-the-art detectors including YOLOv12s and YOLOv12n. The proposed model successfully optimizes the trade-off between missed detections and false alarms, exhibiting highly robust overall object detection capabilities for complex clinical applications, particularly in the automated screening and localization of malignant pulmonary lesions.

Indexed as

Lung NeoplasmsMultiple Pulmonary NodulesRadiographic Image Interpretation, Computer-AssistedTomography, X-Ray ComputedAlgorithmsDeep LearningDetection AlgorithmsHumansDynamic upsamplingFine-grained lung cancer detectionLarge separable kernel attentionMedical image analysisYOLOv12n

Identifiers

PMID42331889
PMCPMC13574773

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.